Developers

Developer Name Compounds Regimens Trials
Anacor Pharmaceuticals
AstraZeneca
Boston University
CDC TBTC
EDCTP
German Center for Infection Research (DZIF)
GlaxoSmithKline
Global Alliance for TB Drug Development
Hans-Knöll Institute, Jena
iM4TB - Innovative Medicines for Tuberculosis
Institute of Materia Medica
IUATLD, Inc.
Janssen Research & Development, LLC
Lilly TB Drug Discovery Initiative
Médecins Sans Frontières France
Medecins Sans Frontieres, The Netherlands
Michigan State University
Microbiotix, Inc.
Nearmedic Plus LLC
NIAID, NIH, DHHS
Novartis
Otsuka Pharmaceutical Development & Commercialization, Inc.
PanACEA
Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
Qurient Co., Ltd
Sanofi
Sequella, Inc
Spero Therapeutics, LLC
SPRINT TB (National University of Singapore)
St. George's Hospital University of London
The Aurum Institute NPC
University of Auckland
University of Illinois at Chicago
University of Munich
USAID
Weill Medical College of Cornell University